Sunil A David

10PUBLICATIONS
23CO-AUTHORS
Molecular targetsBiomedical instrumentationGlycoconjugatesInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 01, 2022
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors.

Judith Stickdorn, Lara Stein, Danielle Arnold-Schild

|Sep 13, 2021
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering.

Jingen Zhu, Neeti Ananthaswamy, Swati Jain

|Jun 24, 2021
Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7/8 Agonistic Immune Modulators.

Anne Huppertsberg, Leonard Kaps, Zifu Zhong

|Jan 28, 2021
Lipid-Polyglutamate Nanoparticle Vaccine Platform.

Dorien Van Lysebetten, Alessio Malfanti, Kim Deswarte

|Jan 18, 2021
Imidazoquinoline-Conjugated Degradable Coacervate Conjugate for Local Cancer Immunotherapy.

Hui Li, Simon Van Herck, Yongjun Liu

|Jun 12, 2020
Potent and Prolonged Innate Immune Activation by Enzyme-Responsive Imidazoquinoline TLR7/8 Agonist Prodrug Vesicles.

Bi Wang, Simon Van Herck, Yong Chen

Pageof 2

Frequent Collaborators

7 joint publications

Bruno G De Geest

5 joint publications

Niek N Sanders

3 joint publications

Lutz Nuhn

3 joint publications

Kaloian Koynov